Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Table of contents

May 2016 - Volume 19 - 2

Evidence Based Mental Health: 19 (2)

Perspective

mHealth in psychiatry: time for methodological change (21 April, 2016)
Jennifer Nicholas, Katherine Boydell, Helen Christensen

Clinical reviews

Ketamine for treatment-resistant depression: recent developments and clinical applications (21 April, 2016) Free
Jaclyn Schwartz, James W Murrough, Dan V Iosifescu
Are all psychotherapies equally effective in the treatment of adult depression? The lack of statistical power of comparative outcome studies (21 April, 2016) Free
Pim Cuijpers
Computerised cognitive behaviour therapy for major depression: a reply to the REEACT trial (21 April, 2016)
Gavin Andrews, Megan J Hobbs, Jill M Newby

Evidence-based case conference

Diagnosing autism spectrum disorder (ASD) among adults (21 April, 2016)
Toshi A Furukawa

Statistics in practice

Economic evaluation of mental health interventions: an introduction to cost-utility analysis (21 April, 2016) Free
Jeroen Luyten, Huseyin Naci, Martin Knapp

Causes and risk factors

High-potency cannabis increases the risk of psychosis (21 April, 2016)
Emma Barkus
Impact of additive alcohol and substance use disorders on the mortality of people with schizophrenia and mood disorders (21 April, 2016)
Chin-Kuo Chang
Support for the link between adolescent mental health problems and subsequent perinatal depression: a 20-year prospective cohort study (21 April, 2016)
Wendy Nilsen

Outcomes

Treatment of maternal perinatal depression in a low-income setting does not lead to improved outcomes for children (21 April, 2016)
Paul G Ramchandani, Dorothy X King
Psychotic disorders cause the greatest mortality disparity among mental disorders, though more deaths are attributable overall to mood and anxiety disorders (21 April, 2016)
Daniel W Bradford, Natasha Cunningham

Miscellaneous

A negative randomised sham-controlled trial of ventral capsule/ventral striatum stimulation in treatment-resistant depression: an unsuccessful trial or treatment? (21 April, 2016)
Rajamannar Ramasubbu

Pharmacological interventions

Alpha-7 nicotinic agonist improves cognition in schizophrenia (21 April, 2016)
Stephen R. Marder
Lack of improvement at week 2 predicts later antipsychotic non-response in people with acute exacerbations of schizophrenia or schizophrenia-like psychosis (21 April, 2016)
Taro Kishi
Unnecessary psychotropic drug prescription in primary care for people with intellectual disability (21 April, 2016)
Julian Trollor, Carmela Salomon

Psychological interventions

Psychodynamic therapy: a poorly defined concept with questionable evidence (21 April, 2016)
Stefan G Hofmann

Letter

Psychodynamic therapy: a well-defined concept with increasing evidence (21 April, 2016)
Falk Leichsenring, Allan Abbass, William Gottdiener, Mark Hilsenroth, John R Keefe, Patrick Luyten, Sven Rabung, Christiane Steinert

Electronic pages

Pharmacological interventions: Which role for brexpiprazole, a new dopamine D2 partial agonist, in the treatment of schizophrenia? (21 April, 2016)
Leslie Citrome
Pharmacological interventions: Some augmentation strategies improve outcome but increase discontinuation in adults with treatment-resistant depression (21 April, 2016)
Chittaranjan Andrade
Pharmacological interventions: Long-acting injectable risperidone as an option in first-episode psychosis (21 April, 2016)
Nancy H Covell
Pharmacological interventions: Clonidine: new use of an old medication to reduce stress-related substance use (21 April, 2016)
George Woody

Issue Information